Vimpat
® (
lacosamide) is a prescription medication approved to treat certain
types of seizures (known as partial-onset
seizures, partial
seizures, or focal seizures) in people 17 years old and older. It is approved for use only in combination with other seizure medications.
(Click Vimpat Uses for more information on what the medication is used for, including possible off-label uses.)
Vimpat is made by UCB, Inc.
Seizures are the result of brief changes in how the brain's electrical system works. It is not known exactly how Vimpat works for treating seizures. Studies suggest that it may work by affecting sodium channels in the brain, preventing the abnormal activity from "firing" and spreading to other parts of the brain. This action helps control seizures.
This medication has been thoroughly evaluated in clinical studies.
These studies evaluated Vimpat in people with partial-onset seizures whose seizures were not adequately controlled with their current medications. In one study, adding Vimpat significantly reduced seizure frequency by up to 40 percent, compared to only 10 percent in those people who were given a placebo (a "sugar pill" that does not contain any active ingredients) in addition to their regular seizure medications.